Cargando…
Regression of Lung Squamous Cell Carcinoma after the Withdrawal of Cyclosporin A Combined with Pirfenidone Treatment in a Patient with Idiopathic Pulmonary Fibrosis
A 72-year-old man was treated with prednisolone and cyclosporine A for idiopathic pulmonary fibrosis. A nodule with a diameter of 19 mm was found in the right lung and diagnosed as lung squamous cell carcinoma. Anti-cancer treatments were not performed because of the presence of advanced interstitia...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7946518/ https://www.ncbi.nlm.nih.gov/pubmed/33028767 http://dx.doi.org/10.2169/internalmedicine.5125-20 |
_version_ | 1783663068450914304 |
---|---|
author | Takahashi, Mari Horio, Yukihiro Takihara, Takahisa Enokida, Keito Miyaoka, Masashi Hirabayashi, Kenichi Ohshinden, Kana Hattori, Shigeaki Takahashi, Fuminari Takahashi, Genki Tanaka, Jun Takiguchi, Hiroto Niimi, Kyoko Ito, Yoko Hayama, Naoki Oguma, Tsuyoshi Asano, Koichiro |
author_facet | Takahashi, Mari Horio, Yukihiro Takihara, Takahisa Enokida, Keito Miyaoka, Masashi Hirabayashi, Kenichi Ohshinden, Kana Hattori, Shigeaki Takahashi, Fuminari Takahashi, Genki Tanaka, Jun Takiguchi, Hiroto Niimi, Kyoko Ito, Yoko Hayama, Naoki Oguma, Tsuyoshi Asano, Koichiro |
author_sort | Takahashi, Mari |
collection | PubMed |
description | A 72-year-old man was treated with prednisolone and cyclosporine A for idiopathic pulmonary fibrosis. A nodule with a diameter of 19 mm was found in the right lung and diagnosed as lung squamous cell carcinoma. Anti-cancer treatments were not performed because of the presence of advanced interstitial pneumonia and chronic respiratory failure. Cyclosporine A was tapered to avoid suppression of anti-tumor immunity, and pirfenidone was initiated. Within 2 months, the tumor had shrunk to 10 mm in diameter and remained regressed for 9 months. This is the first report of a non-hematologic solid organ tumor responding to the discontinuation of immunosuppressants. |
format | Online Article Text |
id | pubmed-7946518 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | The Japanese Society of Internal Medicine |
record_format | MEDLINE/PubMed |
spelling | pubmed-79465182021-03-15 Regression of Lung Squamous Cell Carcinoma after the Withdrawal of Cyclosporin A Combined with Pirfenidone Treatment in a Patient with Idiopathic Pulmonary Fibrosis Takahashi, Mari Horio, Yukihiro Takihara, Takahisa Enokida, Keito Miyaoka, Masashi Hirabayashi, Kenichi Ohshinden, Kana Hattori, Shigeaki Takahashi, Fuminari Takahashi, Genki Tanaka, Jun Takiguchi, Hiroto Niimi, Kyoko Ito, Yoko Hayama, Naoki Oguma, Tsuyoshi Asano, Koichiro Intern Med Case Report A 72-year-old man was treated with prednisolone and cyclosporine A for idiopathic pulmonary fibrosis. A nodule with a diameter of 19 mm was found in the right lung and diagnosed as lung squamous cell carcinoma. Anti-cancer treatments were not performed because of the presence of advanced interstitial pneumonia and chronic respiratory failure. Cyclosporine A was tapered to avoid suppression of anti-tumor immunity, and pirfenidone was initiated. Within 2 months, the tumor had shrunk to 10 mm in diameter and remained regressed for 9 months. This is the first report of a non-hematologic solid organ tumor responding to the discontinuation of immunosuppressants. The Japanese Society of Internal Medicine 2020-10-07 2021-02-15 /pmc/articles/PMC7946518/ /pubmed/33028767 http://dx.doi.org/10.2169/internalmedicine.5125-20 Text en Copyright © 2021 by The Japanese Society of Internal Medicine https://creativecommons.org/licenses/by-nc-nd/4.0/ The Internal Medicine is an Open Access journal distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Case Report Takahashi, Mari Horio, Yukihiro Takihara, Takahisa Enokida, Keito Miyaoka, Masashi Hirabayashi, Kenichi Ohshinden, Kana Hattori, Shigeaki Takahashi, Fuminari Takahashi, Genki Tanaka, Jun Takiguchi, Hiroto Niimi, Kyoko Ito, Yoko Hayama, Naoki Oguma, Tsuyoshi Asano, Koichiro Regression of Lung Squamous Cell Carcinoma after the Withdrawal of Cyclosporin A Combined with Pirfenidone Treatment in a Patient with Idiopathic Pulmonary Fibrosis |
title | Regression of Lung Squamous Cell Carcinoma after the Withdrawal of Cyclosporin A Combined with Pirfenidone Treatment in a Patient with Idiopathic Pulmonary Fibrosis |
title_full | Regression of Lung Squamous Cell Carcinoma after the Withdrawal of Cyclosporin A Combined with Pirfenidone Treatment in a Patient with Idiopathic Pulmonary Fibrosis |
title_fullStr | Regression of Lung Squamous Cell Carcinoma after the Withdrawal of Cyclosporin A Combined with Pirfenidone Treatment in a Patient with Idiopathic Pulmonary Fibrosis |
title_full_unstemmed | Regression of Lung Squamous Cell Carcinoma after the Withdrawal of Cyclosporin A Combined with Pirfenidone Treatment in a Patient with Idiopathic Pulmonary Fibrosis |
title_short | Regression of Lung Squamous Cell Carcinoma after the Withdrawal of Cyclosporin A Combined with Pirfenidone Treatment in a Patient with Idiopathic Pulmonary Fibrosis |
title_sort | regression of lung squamous cell carcinoma after the withdrawal of cyclosporin a combined with pirfenidone treatment in a patient with idiopathic pulmonary fibrosis |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7946518/ https://www.ncbi.nlm.nih.gov/pubmed/33028767 http://dx.doi.org/10.2169/internalmedicine.5125-20 |
work_keys_str_mv | AT takahashimari regressionoflungsquamouscellcarcinomaafterthewithdrawalofcyclosporinacombinedwithpirfenidonetreatmentinapatientwithidiopathicpulmonaryfibrosis AT horioyukihiro regressionoflungsquamouscellcarcinomaafterthewithdrawalofcyclosporinacombinedwithpirfenidonetreatmentinapatientwithidiopathicpulmonaryfibrosis AT takiharatakahisa regressionoflungsquamouscellcarcinomaafterthewithdrawalofcyclosporinacombinedwithpirfenidonetreatmentinapatientwithidiopathicpulmonaryfibrosis AT enokidakeito regressionoflungsquamouscellcarcinomaafterthewithdrawalofcyclosporinacombinedwithpirfenidonetreatmentinapatientwithidiopathicpulmonaryfibrosis AT miyaokamasashi regressionoflungsquamouscellcarcinomaafterthewithdrawalofcyclosporinacombinedwithpirfenidonetreatmentinapatientwithidiopathicpulmonaryfibrosis AT hirabayashikenichi regressionoflungsquamouscellcarcinomaafterthewithdrawalofcyclosporinacombinedwithpirfenidonetreatmentinapatientwithidiopathicpulmonaryfibrosis AT ohshindenkana regressionoflungsquamouscellcarcinomaafterthewithdrawalofcyclosporinacombinedwithpirfenidonetreatmentinapatientwithidiopathicpulmonaryfibrosis AT hattorishigeaki regressionoflungsquamouscellcarcinomaafterthewithdrawalofcyclosporinacombinedwithpirfenidonetreatmentinapatientwithidiopathicpulmonaryfibrosis AT takahashifuminari regressionoflungsquamouscellcarcinomaafterthewithdrawalofcyclosporinacombinedwithpirfenidonetreatmentinapatientwithidiopathicpulmonaryfibrosis AT takahashigenki regressionoflungsquamouscellcarcinomaafterthewithdrawalofcyclosporinacombinedwithpirfenidonetreatmentinapatientwithidiopathicpulmonaryfibrosis AT tanakajun regressionoflungsquamouscellcarcinomaafterthewithdrawalofcyclosporinacombinedwithpirfenidonetreatmentinapatientwithidiopathicpulmonaryfibrosis AT takiguchihiroto regressionoflungsquamouscellcarcinomaafterthewithdrawalofcyclosporinacombinedwithpirfenidonetreatmentinapatientwithidiopathicpulmonaryfibrosis AT niimikyoko regressionoflungsquamouscellcarcinomaafterthewithdrawalofcyclosporinacombinedwithpirfenidonetreatmentinapatientwithidiopathicpulmonaryfibrosis AT itoyoko regressionoflungsquamouscellcarcinomaafterthewithdrawalofcyclosporinacombinedwithpirfenidonetreatmentinapatientwithidiopathicpulmonaryfibrosis AT hayamanaoki regressionoflungsquamouscellcarcinomaafterthewithdrawalofcyclosporinacombinedwithpirfenidonetreatmentinapatientwithidiopathicpulmonaryfibrosis AT ogumatsuyoshi regressionoflungsquamouscellcarcinomaafterthewithdrawalofcyclosporinacombinedwithpirfenidonetreatmentinapatientwithidiopathicpulmonaryfibrosis AT asanokoichiro regressionoflungsquamouscellcarcinomaafterthewithdrawalofcyclosporinacombinedwithpirfenidonetreatmentinapatientwithidiopathicpulmonaryfibrosis |